Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting)

Sorayya Ghasemi1,2, Suowen Xu3, Seyed Mohammad Nabavi4

  • 1Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Phytotherapy Research : PTR
|February 23, 2021
PubMed

Insights

Epigenetic modifications influence cancer development and stem cell pathways. Phenolic compounds show promise in targeting these epigenetic changes for cancer treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Epigenetic alterations are key drivers of gene dysregulation, impacting cancer carcinogenicity and progression.
  • Cancer stem cells (CSCs) contribute significantly to cancer recurrence, metastasis, and treatment resistance.
  • Epigenetic mechanisms like DNA methylation and chromatin remodeling regulate CSC-specific pathways.

Purpose of the Study:

  • To introduce known epigenetic changes in cancer stem cells.
  • To review the use of phenolic compounds in targeting CSCs via epigenetic mechanisms.
  • To explore the potential of epigenetic therapies involving phenolic compounds for cancer treatment.

Main Methods:

  • Review of existing literature on epigenetic alterations in cancer stem cells.
  • Analysis of studies investigating the effects of phenolic compounds on CSCs.
  • Examination of epigenetic mechanisms targeted by polyphenols.

Main Results:

  • Epigenetic modifications are crucial in cancer stem cell biology.
  • Phenolic compounds possess anticarcinogenic, anti-inflammatory, and antioxidative properties.
  • Evidence suggests polyphenols can modulate CSC development and metabolism through epigenetic pathways.

Conclusions:

  • Epigenetic therapies targeting CSCs represent a novel and promising cancer treatment strategy.
  • Phenolic compounds demonstrate potential as therapeutic agents against CSCs by influencing epigenetic mechanisms.
  • Further research into polyphenol-based epigenetic interventions could lead to improved cancer patient outcomes.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K